This is a community-generated profile. If you work at BioCryst Pharmaceuticals, to claim it.
DiscoverStartupsBioCryst PharmaceuticalsBioCryst Pharmaceuticals Funding Rounds, Valuation & Investors
BioCryst Pharmaceuticals company logo
Develops oral medicines for rare & autoimmune diseases and antivirals501-1000 Employees
View 0 jobs

BioCryst Pharmaceuticals Funding

$4.3M
22 rounds
BioCryst Pharmaceuticals is active in the following markets / industries: biotechnology. The company has secured funding across 2 rounds, totaling in an amount of $4.3M. Their most recent funding was raised on August 29, 2014.

Funding Rounds

U
$2400000
U
$1900000

Investors of BioCryst Pharmaceuticals

National Institute of Allergy and Infectious Diseases (NIAID)
Avatar for National Institute of Allergy and Infectious Diseases (NIAID)
Rounds
U